DAXOR CORP (DXR) has 8 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 1, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 1, 2026 filed Aug. 28, 2026 | Jefferies John Chief Medical Officer | $0 | 2,451 | +10% | No | |
|
|
||||||
| June 25, 2026 filed June 23, 2026 | Michel Robert J Chief Financial Officer | $0 | 12,000 | +57% | No | |
|
|
||||||
| June 25, 2026 filed June 23, 2026 | Feldschuh Michael Richard Chief Executive Officer | $0 | 30,000 | +14% | No | |
|
|
||||||
| June 25, 2026 filed June 23, 2026 | Feldschuh Jonathan Adam Chief Scientific Officer | $0 | 25,000 | +46% | No | |
|
|
||||||
| June 25, 2026 filed June 23, 2026 | Goudie Joy S. Director | $0 | 2,500 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 8 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free